Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.2544
BATS BZX Real-Time Price
As of 10:31am ET
 +0.0232 / +10.03%
Today’s Change
0.21
Today|||52-Week Range
0.40
+1.76%
Year-to-Date

Today’s Trading

Previous close0.23
Today’s open0.25
Day’s range0.24 - 0.25
Volume715,751
Average volume (3 months)2,051,078
Market cap$49.7M
Dividend yield--
Data as of 10:16am ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+31.33%
P/E ratioNM
Price/Sales238.95
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...+0.08+3.52%
OGXIOncoGenex Pharmaceut...-0.07-3.24%
GNVCGenVec Inc-0.04-1.42%
IMNPImmune Pharmaceutica...-0.02-1.02%
Data as of 10:27am ET, 04/28/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$197.0K
Annual profit (last year)-$17.5M
Net profit margin-8,857.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CSO
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers